Yahoo Finance

Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology

PONTE VEDRA, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...
Nasdaq

Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference

PONTE VEDRA, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...
Seeking Alpha

Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion Technology

PONTE VEDRA, Fla., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts (TMCI), Inc. , a medical technology company driving a fundamental shift in the surgical treatment of bunions and related ...
Morningstar

Treace Announces Peer-Reviewed Publication of Four-Year Results of the ALIGN3D™ Lapiplasty® Multicenter Prospective Clinical Study | Morningstar

Treace has pioneered and patented the Lapiplasty ® 3D Bunion Correction ® System – a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the ...
Yahoo Finance

Treace Medical Concepts Q4 Earnings Call Highlights

The company is expanding beyond Lapiplasty with three newer systems (Nanoplasty, Percuplasty and SpeedMTP) to address the roughly 75% of bunion procedures it previously didn't serve, and reported ...
The Globe and Mail

Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology

Treace Medical Concepts, Inc. - GlobeNewswire - Thu Jan 8, 3:05PM CST PONTE VEDRA, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a ...